Micropapillary breast carcinoma in comparison with invasive duct carcinoma. Does it have an aggressive clinical presentation and an unfavorable prognosis?

The results from our PSM analysis suggested that there was no statistically significant difference in prognosis between IMPC and IDC patients after matching them with similar clinical characteristics. However, IMPC was found to be more aggressive, had larger tumor size, greater lymph node metastasis rate and an advanced tumor stage.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2024-08-12
DOI
https://doi.org/10.1186/s12885-024-12673-0
Citations
5
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
1.43

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Micropapillary breast carcinoma in comparison with invasive duct carcinoma. Does it have an aggressive clinical presentation and an unfavorable prognosis?

Mona Mamdouh, Mahmoud Hassaan, Inas Moaz, Amira H. Radwan et al.
5 citations
BMC Cancer
Breast Cancer Treatment Studies
1.43
article

Micropapillary breast carcinoma in comparison with invasive duct carcinoma. Does it have an aggressive clinical presentation and an unfavorable prognosis?

Mona Mamdouh, Mahmoud Hassaan, Inas Moaz, Amira H. Radwan, Sherihan W. Y. Gareer, Osama Abdel Mohen, Mohamed Fathy Abdelfattah Abdelrahm Elithy, Abdelrahman Mohammad Khalifa, Yasmine Hany Abdel Moamen Elzohery
article en
5 citations

Abstract

The results from our PSM analysis suggested that there was no statistically significant difference in prognosis between IMPC and IDC patients after matching them with similar clinical characteristics. However, IMPC was found to be more aggressive, had larger tumor size, greater lymph node metastasis rate and an advanced tumor stage.

BMC CancerVol. 24(1)
Ain Shams University (EG), Cairo University (EG), Al-Azhar University (EG), Breast Cancer Research Foundation (US), National Heart Institute (EG), Menoufia University (EG)
Ain Shams University, Science and Technology Development Fund
Good health and well-being
Openalex Percentile: Top 18%
Breast Cancer Treatment Studies
1.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Micropapillary breast carcinoma in comparison with invasive duct carcinoma. Does it have an aggressive clinical presentation and an unfavorable prognosis? — Mona Mamdouh, Mahmoud Hassaan, et al. · BMC Cancer (2024) | TGRS Research Map | TGRS